Before joining Monte Rosa, Ajim served as CFO of Rodin Therapeutics, where he was integral in the sale of the company to Alkermes for consideration in aggregate value of up to $950 million. He was previously focused on life sciences investing and managed a global portfolio of biotech and pharmaceutical companies, notably as a founding partner of...
Roles at Monte Rosa Therapeutics
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at Monte Rosa Therapeutics
My pet peeves
My communication style